1 - 10 out of 17Page size: 10
  1. 2017

  2. Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines

    Dolskiy, A. A., Pustylnyak, V. O., Yarushkin, A. A., Lemskaya, N. A. & Yudkin, D. V., 1 Jan 2017, In: BioMed Research International. 2017, p. 3582601 5 p., 3582601.

    Research output: Contribution to journal › Article › peer-review

  3. Peroxisome proliferator-activated receptor γ activation inhibits liver growth through miR-122-mediated downregulation of cMyc

    Yarushkin, A. A., Kazantseva, Y. A., Kobelev, V. S., Pustylnyak, Y. A. & Pustylnyak, V. O., 15 Feb 2017, In: European Journal of Pharmacology. 797, p. 39-44 6 p.

    Research output: Contribution to journal › Article › peer-review

  4. 2018

  5. Increased expression of miR-155 and miR-222 is associated with lymph node positive status

    Chernyy, V., Pustylnyak, V., Kozlov, V. & Gulyaeva, L., 1 Jan 2018, In: Journal of Cancer. 9, 1, p. 135-140 6 p.

    Research output: Contribution to journal › Article › peer-review

  6. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients

    Geletina, N. S., Kobelev, V. S., Babayants, E. V., Feng, L., Pustylnyak, V. O. & Gulyaeva, L. F., 20 May 2018, In: Gene. 655, p. 20-24 5 p.

    Research output: Contribution to journal › Article › peer-review

  7. CAR-mediated repression of Cdkn1a(p21) is accompanied by the Akt activation

    Yarushkin, A. A., Mazin, M. E., Yunusova, A. Y., Korchagina, K. V., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 2 Oct 2018, In: Biochemical and Biophysical Research Communications. 504, 2, p. 361-366 6 p.

    Research output: Contribution to journal › Article › peer-review

  8. 2019

  9. Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Sept 2019, In: Archives of Biochemistry and Biophysics. 672, p. 108065 7 p., 108065.

    Research output: Contribution to journal › Article › peer-review

  10. 2020

  11. Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Jul 2020, In: European Journal of Pharmacology. 879, 5 p., 173135.

    Research output: Contribution to journal › Article › peer-review

  12. Noncanonical constitutive androstane receptor signaling in gene regulation

    Pustylnyak, Y. A., Gulyaeva, L. F. & Pustylnyak, V. O., 14 Sept 2020, In: International Journal of Molecular Sciences. 21, 18, p. 1-10 10 p., 6735.

    Research output: Contribution to journal › Review article › peer-review

  13. 2021

  14. miRNA expression and interaction with the 3′UTR of FMR1 in FRAXopathy pathogenesis

    Dolskiy, A. A., Yarushkin, A. A., Grishchenko, I. V., Lemskaya, N. A., Pindyurin, A. V., Boldyreva, L. V., Pustylnyak, V. O. & Yudkin, D. V., Mar 2021, In: Non-coding RNA Research. 6, 1, p. 1-7 7 p.

    Research output: Contribution to journal › Article › peer-review

  15. 2022

  16. Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation

    Mazin, M. E., Yarushkin, A. A., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., May 2022, In: Molecular Biology Reports. 49, 5, p. 4089-4093 5 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next

ID: 3444310